Australian PIP implant surgery promises new insight into failures
This article was originally published in Clinica
An Australian recipient of the controversial Poly Implant Prothèse (PIP) implants has undergone replacement surgery for the second time on the same breast in less than two months, Clinica has learnt.
You may also be interested in...
HAL Allergy Group, developer of products for allergy diagnostics and allergen immunotherapy, promoted its principal scientist to chief R&D officer; Starkey Hearing Technologies brought on new health and business development execs to expand its global footprint; and more.
As the coronavirus continues to spread, one of the big four global vaccines companies has committed itself to the fight.